Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system Tissue Antigens 2000; 60:407-64
Olerup O, Zetterquist H. HLA-DR typing by PCR ampliıfication with sequence specific primers (PCR-SSP) in 2 hours:an alternative to serological DR typing in clini- cal practice including donor-recipient matching in cadav- eric transplantation. Tissue Antigens 1992; 39:225-35.
Patel R Terasaki PI. Significance of the positive crossımatch test in kidney transplantation New Eng J Med 1969:280:14:735-39.
Lu KC. Tissue and solid organ allograft rejection In Austen KF, Frank MM, Atkinson JP Cantor H (eds) Samter’s Immunologic Diseases sixth edition Lippincot Williams and Wilkins 2001; p:1121-32.
Kuby J. Major histocompatibility complex. Immunology. 3th ed. New York: Van Hoffman Press; 1997; p.223-48.
Gülmezoglu E, Ergüven S. Tissue compability tests. Immunology, Ankara: Hacettepe-Tas publication; 1994. p.29-40. (Turkish).
Ersoy F. Tissue groups in Turkish population (HLA). J Pediatric Diseases 1980;23: 79-85 (Turkish).
Yeğin O: HLA antigens in patients who have chronic kidney insufficiency and controls Akdeniz University Medicine Faculty Journal V. 1988; 131-137. (Turkish).
Talbot D. Renal transplantation: origins and future. Int Surg 1999;84:291-6.
Shapiro R. Outcome after renal transplantation. in : Shapiro R, Simmons RL, Starzl TE. Renal Transplantation. London. Appleton Lange 1997;p:1.
Yu L, Xu J, Ye G et al. Retrospective evaluation of 2123 cases of kidney transıplantation. Zhonghua Wai Ke Za Zhi 2002;40:248-50.
Kasiske BL. The evaluation of prospective renal transıplant recipients and living donors. Surg Clin Norh Am 1998:78:27.
Panigrahi A, Agarwal SK,Kanga U et al. Influence of HLA compatibility on renal graft survival using live unrelatıed & cadaver donors in India. Indian J Med Res 2002;115:158- 64.
Iniotaki-Theodoraki A. The role of HLA class I and class II antibodies in renal transplantation. Nephrol Dial Transplant 2002;16:150-2.
Keçecioğlu N. The importance of waiting list and preparaıtion process. Yücetin L. Organ transplanta- tion coordinaıtion book, 1. publication, 2002; p:138-9 (Turkish).
THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS
Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system Tissue Antigens 2000; 60:407-64
Olerup O, Zetterquist H. HLA-DR typing by PCR ampliıfication with sequence specific primers (PCR-SSP) in 2 hours:an alternative to serological DR typing in clini- cal practice including donor-recipient matching in cadav- eric transplantation. Tissue Antigens 1992; 39:225-35.
Patel R Terasaki PI. Significance of the positive crossımatch test in kidney transplantation New Eng J Med 1969:280:14:735-39.
Lu KC. Tissue and solid organ allograft rejection In Austen KF, Frank MM, Atkinson JP Cantor H (eds) Samter’s Immunologic Diseases sixth edition Lippincot Williams and Wilkins 2001; p:1121-32.
Kuby J. Major histocompatibility complex. Immunology. 3th ed. New York: Van Hoffman Press; 1997; p.223-48.
Gülmezoglu E, Ergüven S. Tissue compability tests. Immunology, Ankara: Hacettepe-Tas publication; 1994. p.29-40. (Turkish).
Ersoy F. Tissue groups in Turkish population (HLA). J Pediatric Diseases 1980;23: 79-85 (Turkish).
Yeğin O: HLA antigens in patients who have chronic kidney insufficiency and controls Akdeniz University Medicine Faculty Journal V. 1988; 131-137. (Turkish).
Talbot D. Renal transplantation: origins and future. Int Surg 1999;84:291-6.
Shapiro R. Outcome after renal transplantation. in : Shapiro R, Simmons RL, Starzl TE. Renal Transplantation. London. Appleton Lange 1997;p:1.
Yu L, Xu J, Ye G et al. Retrospective evaluation of 2123 cases of kidney transıplantation. Zhonghua Wai Ke Za Zhi 2002;40:248-50.
Kasiske BL. The evaluation of prospective renal transıplant recipients and living donors. Surg Clin Norh Am 1998:78:27.
Panigrahi A, Agarwal SK,Kanga U et al. Influence of HLA compatibility on renal graft survival using live unrelatıed & cadaver donors in India. Indian J Med Res 2002;115:158- 64.
Iniotaki-Theodoraki A. The role of HLA class I and class II antibodies in renal transplantation. Nephrol Dial Transplant 2002;16:150-2.
Keçecioğlu N. The importance of waiting list and preparaıtion process. Yücetin L. Organ transplanta- tion coordinaıtion book, 1. publication, 2002; p:138-9 (Turkish).
Erikoğlu, M., Büyükdoğan, M., & Cora, T. (2011). THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS. European Journal of General Medicine, 8(1), 65-68.
AMA
Erikoğlu M, Büyükdoğan M, Cora T. THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS. European Journal of General Medicine. Mart 2011;8(1):65-68.
Chicago
Erikoğlu, Mehmet, Murat Büyükdoğan, ve Tülin Cora. “THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS”. European Journal of General Medicine 8, sy. 1 (Mart 2011): 65-68.
EndNote
Erikoğlu M, Büyükdoğan M, Cora T (01 Mart 2011) THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS. European Journal of General Medicine 8 1 65–68.
IEEE
M. Erikoğlu, M. Büyükdoğan, ve T. Cora, “THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS”, European Journal of General Medicine, c. 8, sy. 1, ss. 65–68, 2011.
ISNAD
Erikoğlu, Mehmet vd. “THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS”. European Journal of General Medicine 8/1 (Mart 2011), 65-68.
JAMA
Erikoğlu M, Büyükdoğan M, Cora T. THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS. European Journal of General Medicine. 2011;8:65–68.
MLA
Erikoğlu, Mehmet vd. “THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS”. European Journal of General Medicine, c. 8, sy. 1, 2011, ss. 65-68.
Vancouver
Erikoğlu M, Büyükdoğan M, Cora T. THE RELATIONSHIP BETWEEN HLA ANTIGENS AND BLOOD GROUPS. European Journal of General Medicine. 2011;8(1):65-8.